Article Details
Retrieved on: 2021-07-21 18:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BioNTech is buying the facility from Kite Pharma, a subsidiary of Gilead Sciences. It is also acquiring Kite's platform for developing T-cell receptor ...
Article found on: wtop.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here